60 Degrees Pharmaceutical... (SXTP)
NASDAQ: SXTP
· Real-Time Price · USD
1.40
-0.04 (-2.64%)
At close: Oct 03, 2025, 3:59 PM
1.42
1.43%
After-hours: Oct 03, 2025, 04:38 PM EDT
60 Degrees Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 307.87K | 256.28K | 261.44K | 135.29K | 125.7K | 146.09K | 42.71K | 51.19K | 59.53K | 17.17K | -75.65K | 168.19K | 45.17K | 47.02K | 29.46K |
Cost of Revenue | 50.05K | 73.27K | 118.08K | 111.69K | 89.56K | 65.44K | 146.26K | 71.2K | 183.98K | 73.12K | 124.36K | 92.28K | 87.12K | 90.13K | 71.62K |
Gross Profit | 50.88K | 90.28K | 112.77K | 23.61K | 36.14K | 80.66K | -103.55K | 62.97K | -124.44K | -55.95K | -200.01K | 75.9K | -41.95K | -43.11K | -42.16K |
Operating Income | -1.6M | -1.91M | -2.08M | -2.12M | -4.19M | -1.33M | -1.89M | -1.52M | -788K | -950.66K | -684.7K | -215.12K | -686.92K | -163.71K | -481.89K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 428.05K | -2.05M | 4.17M | -3.34M | -2.6M | -1.92M | -1.45M | -2.15M | -907.2K | -1.36M |
Net Income | -1.72M | -1.88M | -2.05M | -2.16M | -4.17M | 430.47K | -2.01M | 4.18M | -3.34M | -2.6M | -1.92M | -1.45M | -2.15M | -912.28K | -1.36M |
Selling & General & Admin | 1.61M | 1.69M | 1.61M | 1.22M | 1.13M | 1.08M | 1.69M | 1.31M | 462.8K | 775.01K | 464.56K | 413.63K | 405.84K | 174.69K | 263.17K |
Research & Development | 249.88K | 407.62K | 613.96K | 940.06K | 3.1M | 337.18K | 100.2K | 263.7K | 203.87K | 123.99K | 203.46K | 27.66K | 231.39K | 63.06K | 433.74K |
Other Expenses | n/a | -92.73K | n/a | -12.82K | n/a | n/a | n/a | n/a | -3.12K | -4.29K | -13.43K | -150.26K | 7.74K | -117.15K | -257.18K |
Operating Expenses | 1.86M | 2M | 2.22M | 2.14M | 4.22M | 1.41M | 1.79M | 1.58M | 663.55K | 894.72K | 484.69K | 291.02K | 644.97K | 174.69K | 263.17K |
Interest Expense | 1.22K | 1.79K | 1.42K | 1.47K | 3.62K | 1.4K | 5.45K | 40.11K | 1.1M | 1.14M | 1.11M | 1.22M | 905.52K | 762.22K | 921.04K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.91M | 2.17M | 2.34M | 2.27M | 4.31M | 1.48M | 1.94M | 1.65M | 847.53K | 967.84K | 609.05K | 383.3K | 732.09K | 210.74K | 472.85K |
Income Tax Expense | 1.5K | 63.00 | -501 | 250.00 | 438.00 | 63.00 | 61.00 | 63.00 | 63.00 | 63.00 | -250 | 250.00 | 250.00 | 250.00 | 250.00 |
Shares Outstanding (Basic) | 1.47M | 1.28M | 454.58K | 2.44M | 986.9K | 168.76K | 5.81M | 5.8M | 5.8M | 5.57M | 5.57M | 5.57M | 5.57M | 96.83K | 5.81M |
Shares Outstanding (Diluted) | 1.47M | 1.28M | 454.58K | 2.44M | 1.01M | 168.76K | 5.81M | 5.8M | 5.8M | 5.57M | 5.57M | 5.57M | 5.57M | 96.83K | 5.81M |
EPS (Basic) | -1.25 | -1.56 | -4.5 | -0.88 | -4.23 | 1.83 | -0.34 | 0.72 | -0.58 | -0.47 | -0.35 | -0.26 | -0.39 | -1.97 | -0.23 |
EPS (Diluted) | -1.25 | -1.56 | -4.5 | -0.88 | -4.11 | 1.83 | -0.34 | 0.72 | -0.58 | -0.47 | -0.35 | -0.26 | -0.39 | -1.97 | -0.23 |
EBITDA | -1.6M | -1.86M | -2.03M | -2.14M | -4.16M | 451.58K | -2.02M | 4.24M | -2.22M | -1.43M | -791.35K | -215K | -1.23M | -126.17K | -425.33K |
EBIT | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 429.45K | -2.04M | 4.21M | -2.24M | -1.46M | -812.76K | -234.44K | -1.24M | -144.98K | -443.71K |
Depreciation & Amortization | 19.68K | 16.8K | 15.95K | 14.66K | 11.01K | 22.13K | 23.44K | 25.43K | 24.99K | 26.5K | 21.41K | 19.43K | 19.13K | 18.82K | 18.38K |